Appointment of Non-Executive Director

RNS Number : 2128Z
Fevertree Drinks PLC
20 May 2021
 

Fever-Tree Drinks plc

Appointment of Non-Executive Director

 

Fever-Tree, the   world's leading supplier of premium carbonated mixers, is pleased to announce the appointment of Laura Kate Hagan (formerly Runacres, aged 48) as Non-Executive Director of the Company.

 

Laura is currently Chief Human Resource Officer at Tate & Lyle PLC. With over 20 years of experience in HR, Laura has held senior positions at Dyson Ltd, including Group HR Director, along with leading roles in global talent, resourcing and organisational development. Earlier in her career she worked as a management consultant for Arthur Andersen.

Bill Ronald, Chairman of Fever-Tree, comments : "On behalf of the Board, I am delighted to welcome Laura to Fever-Tree. Laura brings a wealth of relevant experience across both listed and founder led businesses that will undoubtedly further strengthen our Board's capabilities."  

Laura Hagan does not currently hold any shares in the Company.

Laura Hagan has no other current directorships. During the past five years, Laura Hagan has been a director of DYSON TECHNICAL TRAINING LIMITED.

There are no further disclosures to be made in accordance with AIM Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies:

For more information please contact:

Investor queries

Ann Hyams, Director of Investor Relations I   ann.hyams@fever-tree.com   I +44 (0)7435 828 138

Media queries

Oliver Winters, Director of Communications I   oliver.winters@fever-tree.com   I +44 (0)770 332 9024

 

Nominated Advisor and Joint Broker - Numis Securities

Garry Levin I Matt Lewis I Hugo Rubinstein I +44 (0)20 7260 1000

Joint Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

Financial PR advisers - Finsbury

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0)   7826 534 233; Amanda Healy +44 (0)7795 051 635

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUGUAUPGPUB
UK 100

Latest directors dealings